Stelara (Ustekinumab) Global Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts

Stelara (Ustekinumab) Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on stelara (ustekinumab) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 10 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-4 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.
Description:

Where is the largest and fastest growing market for stelara (ustekinumab) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The stelara (ustekinumab) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope

Markets Covered:1) By Indication: Plaque Psoriasis; Psoriatic Arthritis; Crohn’s Disease; Ulcerative Colitis; Other Indications

2) By Route Of Administration: Subcutaneous Injection; Intravenous Infusion

3) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy

4) By End User: Pediatric; Adult; Geriatric

Companies Mentioned: Johnson & Johnson

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery format: PDF, Word and Excel Data Dashboard.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.


1. Executive Summary
2. Stelara (Ustekinumab) Market Characteristics
3. Stelara (Ustekinumab) Market Biologic Drug Characteristics
3.1. Molecule Type
3.2. Route Of Administration (ROA)
3.3. Mechanism Of Action (MOA)
3.4. Safety And Efficacy
4. Stelara (Ustekinumab) Market Trends And Strategies
5. Stelara (Ustekinumab) Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
6. Global Stelara (Ustekinumab) Growth Analysis And Strategic Analysis Framework
6.1. Global Stelara (Ustekinumab) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
6.2. Analysis Of End Use Industries
6.3. Global Stelara (Ustekinumab) Market Growth Rate Analysis
6.4. Global Stelara (Ustekinumab) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
6.5. Global Stelara (Ustekinumab) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
6.6. Global Stelara (Ustekinumab) Total Addressable Market (TAM)
7. Global Stelara (Ustekinumab) Market Pricing Analysis & Forecasts
8. Stelara (Ustekinumab) Market Segmentation
8.1. Global Stelara (Ustekinumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Plaque Psoriasis
Psoriatic Arthritis
Crohn’s Disease
Ulcerative Colitis
Other Indications
8.2. Global Stelara (Ustekinumab) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Subcutaneous Injection
Intravenous Infusion
8.3. Global Stelara (Ustekinumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
8.4. Global Stelara (Ustekinumab) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pediatric
Adult
Geriatric
9. Global Stelara (Ustekinumab) Market Epidemiology Of Clinical Indications
9.1. Drug Side Effects
9.2. Incidence And Prevalence of Clinical Indications
10. Stelara (Ustekinumab) Market Regional And Country Analysis
10.1. Global Stelara (Ustekinumab) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. Global Stelara (Ustekinumab) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Asia-Pacific Stelara (Ustekinumab) Market
11.1. Asia-Pacific Stelara (Ustekinumab) Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Stelara (Ustekinumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Asia-Pacific Stelara (Ustekinumab) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Asia-Pacific Stelara (Ustekinumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. China Stelara (Ustekinumab) Market
12.1. China Stelara (Ustekinumab) Market Overview
12.2. China Stelara (Ustekinumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
12.3. China Stelara (Ustekinumab) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
12.4. China Stelara (Ustekinumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
13. India Stelara (Ustekinumab) Market
13.1. India Stelara (Ustekinumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. India Stelara (Ustekinumab) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. India Stelara (Ustekinumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. Japan Stelara (Ustekinumab) Market
14.1. Japan Stelara (Ustekinumab) Market Overview
14.2. Japan Stelara (Ustekinumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. Japan Stelara (Ustekinumab) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. Japan Stelara (Ustekinumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Australia Stelara (Ustekinumab) Market
15.1. Australia Stelara (Ustekinumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.2. Australia Stelara (Ustekinumab) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Australia Stelara (Ustekinumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. South Korea Stelara (Ustekinumab) Market
16.1. South Korea Stelara (Ustekinumab) Market Overview
16.2. South Korea Stelara (Ustekinumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. South Korea Stelara (Ustekinumab) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.4. South Korea Stelara (Ustekinumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Western Europe Stelara (Ustekinumab) Market
17.1. Western Europe Stelara (Ustekinumab) Market Overview
17.2. Western Europe Stelara (Ustekinumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Western Europe Stelara (Ustekinumab) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.4. Western Europe Stelara (Ustekinumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. UK Stelara (Ustekinumab) Market
18.1. UK Stelara (Ustekinumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. UK Stelara (Ustekinumab) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. UK Stelara (Ustekinumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Germany Stelara (Ustekinumab) Market
19.1. Germany Stelara (Ustekinumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Germany Stelara (Ustekinumab) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Germany Stelara (Ustekinumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. France Stelara (Ustekinumab) Market
20.1. France Stelara (Ustekinumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. France Stelara (Ustekinumab) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. France Stelara (Ustekinumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Stelara (Ustekinumab) Market
21.1. Eastern Europe Stelara (Ustekinumab) Market Overview
21.2. Eastern Europe Stelara (Ustekinumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Stelara (Ustekinumab) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Stelara (Ustekinumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. North America Stelara (Ustekinumab) Market
22.1. North America Stelara (Ustekinumab) Market Overview
22.2. North America Stelara (Ustekinumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. North America Stelara (Ustekinumab) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.4. North America Stelara (Ustekinumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. USA Stelara (Ustekinumab) Market
23.1. USA Stelara (Ustekinumab) Market Overview
23.2. USA Stelara (Ustekinumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. USA Stelara (Ustekinumab) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. USA Stelara (Ustekinumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. Canada Stelara (Ustekinumab) Market
24.1. Canada Stelara (Ustekinumab) Market Overview
24.2. Canada Stelara (Ustekinumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. Canada Stelara (Ustekinumab) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. Canada Stelara (Ustekinumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. South America Stelara (Ustekinumab) Market
25.1. South America Stelara (Ustekinumab) Market Overview
25.2. South America Stelara (Ustekinumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. South America Stelara (Ustekinumab) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. South America Stelara (Ustekinumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. Middle East Stelara (Ustekinumab) Market
26.1. Middle East Stelara (Ustekinumab) Market Overview
26.2. Middle East Stelara (Ustekinumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. Middle East Stelara (Ustekinumab) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. Middle East Stelara (Ustekinumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Africa Stelara (Ustekinumab) Market
27.1. Africa Stelara (Ustekinumab) Market Overview
27.2. Africa Stelara (Ustekinumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Africa Stelara (Ustekinumab) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.4. Africa Stelara (Ustekinumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Stelara (Ustekinumab) Market Competitive Landscape And Company Profiles
28.1. Stelara (Ustekinumab) Market Competitive Landscape
28.2. Stelara (Ustekinumab) Market Company Profiles
28.2.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
29. Global Stelara (Ustekinumab) Market Pipeline Analysis
29.1. High Level Clinic Trail Information
30. Global Stelara (Ustekinumab) Market Competitive Benchmarking And Dashboard
31. Key Mergers And Acquisitions In The Stelara (Ustekinumab) Market
32. Recent Developments In The Stelara (Ustekinumab) Market
33. Stelara (Ustekinumab) Market High Potential Countries, Segments and Strategies
33.1 Stelara (Ustekinumab) Market In 2029 - Countries Offering Most New Opportunities
33.2 Stelara (Ustekinumab) Market In 2029 - Segments Offering Most New Opportunities
33.3 Stelara (Ustekinumab) Market In 2029 - Growth Strategies
33.3.1 Market Trend Based Strategies
33.3.2 Competitor Strategies
34. Appendix
34.1. Abbreviations
34.2. Currencies
34.3. Historic And Forecast Inflation Rates
34.4. Research Inquiries
34.5. The Business Research Company
34.6. Copyright And Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings